United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE266.0500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots261.2500/ 5
- Ask / Lots274.8300/ 1
- Open / Previous Close263.8700 / 266.0500
- Day Range
- 52 Week Range
- Volume474,260
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 2378 | 265.135 |
| 09:34 ET | 1200 | 263.89 |
| 09:36 ET | 500 | 264.445 |
| 09:38 ET | 2323 | 262.055 |
| 09:39 ET | 900 | 261.37 |
| 09:41 ET | 600 | 261.24 |
| 09:43 ET | 4542 | 261.22 |
| 09:45 ET | 900 | 261.195 |
| 09:48 ET | 300 | 261.15 |
| 09:50 ET | 5563 | 262.13 |
| 09:52 ET | 654 | 262.22 |
| 09:54 ET | 700 | 262.24 |
| 09:57 ET | 1297 | 262.66 |
| 10:01 ET | 100 | 263.3 |
| 10:03 ET | 200 | 263.035 |
| 10:06 ET | 700 | 263.34 |
| 10:08 ET | 1500 | 263.31 |
| 10:10 ET | 2101 | 262.98 |
| 10:12 ET | 100 | 262.965 |
| 10:15 ET | 300 | 263.98 |
| 10:17 ET | 300 | 263.975 |
| 10:19 ET | 500 | 263.98 |
| 10:24 ET | 700 | 263.98 |
| 10:26 ET | 100 | 264.04 |
| 10:28 ET | 500 | 264.07 |
| 10:30 ET | 3450 | 262.9566 |
| 10:33 ET | 100 | 262.95 |
| 10:35 ET | 200 | 262.89 |
| 10:37 ET | 2800 | 262.73 |
| 10:39 ET | 100 | 262.885 |
| 10:42 ET | 400 | 262.59 |
| 10:44 ET | 200 | 261.85 |
| 10:46 ET | 501 | 262.54 |
| 10:48 ET | 730 | 262.77 |
| 10:50 ET | 1138 | 263.02 |
| 10:51 ET | 200 | 263.17 |
| 10:53 ET | 200 | 263.57 |
| 10:55 ET | 2449 | 263.965 |
| 10:57 ET | 500 | 264.08 |
| 11:00 ET | 2100 | 264.01 |
| 11:02 ET | 300 | 263.85 |
| 11:04 ET | 1798 | 263.42 |
| 11:06 ET | 605 | 262.49 |
| 11:08 ET | 200 | 262.505 |
| 11:09 ET | 200 | 262.45 |
| 11:11 ET | 766 | 262.81 |
| 11:13 ET | 100 | 262.725 |
| 11:15 ET | 200 | 262.97 |
| 11:18 ET | 300 | 262.865 |
| 11:20 ET | 500 | 262.915 |
| 11:22 ET | 1100 | 263.14 |
| 11:26 ET | 450 | 263.37 |
| 11:29 ET | 1900 | 262.515 |
| 11:31 ET | 669 | 262.93 |
| 11:33 ET | 200 | 263.15 |
| 11:36 ET | 100 | 263.165 |
| 11:38 ET | 300 | 263.125 |
| 11:40 ET | 702 | 263.07 |
| 11:42 ET | 2700 | 262.55 |
| 11:44 ET | 900 | 262.715 |
| 11:47 ET | 463 | 262.63 |
| 11:49 ET | 500 | 262.735 |
| 11:51 ET | 200 | 262.84 |
| 11:56 ET | 400 | 262.855 |
| 11:58 ET | 605 | 263.01 |
| 12:00 ET | 1678 | 262.61 |
| 12:03 ET | 100 | 262.645 |
| 12:07 ET | 300 | 262.67 |
| 12:09 ET | 100 | 262.61 |
| 12:14 ET | 622 | 262.49 |
| 12:18 ET | 300 | 262.83 |
| 12:20 ET | 400 | 262.85 |
| 12:23 ET | 300 | 262.865 |
| 12:25 ET | 200 | 262.875 |
| 12:27 ET | 4000 | 262.965 |
| 12:30 ET | 100 | 262.965 |
| 12:32 ET | 200 | 262.975 |
| 12:34 ET | 300 | 262.975 |
| 12:36 ET | 1300 | 263.02 |
| 12:38 ET | 1805 | 263.78 |
| 12:39 ET | 1818 | 263.87 |
| 12:41 ET | 250 | 263.6471 |
| 12:43 ET | 465 | 264.1 |
| 12:45 ET | 400 | 264.2 |
| 12:52 ET | 700 | 264.405 |
| 12:54 ET | 1951 | 264.225 |
| 12:57 ET | 2300 | 263.975 |
| 12:59 ET | 1398 | 263.86 |
| 01:03 ET | 600 | 263.82 |
| 01:06 ET | 200 | 263.85 |
| 01:10 ET | 600 | 263.875 |
| 01:12 ET | 750 | 263.88 |
| 01:14 ET | 3761 | 264.4 |
| 01:15 ET | 1200 | 264.67 |
| 01:17 ET | 1477 | 264.57 |
| 01:19 ET | 16901 | 265.563 |
| 01:21 ET | 100 | 265.16 |
| 01:24 ET | 200 | 265.015 |
| 01:26 ET | 400 | 265.35 |
| 01:32 ET | 300 | 265.41 |
| 01:35 ET | 1182 | 265.5575 |
| 01:37 ET | 1000 | 265.21 |
| 01:39 ET | 358 | 265.81 |
| 01:42 ET | 600 | 265.7 |
| 01:48 ET | 1403 | 265.87 |
| 01:50 ET | 1179 | 265.69 |
| 01:53 ET | 200 | 265.89 |
| 01:55 ET | 400 | 265.8 |
| 02:00 ET | 100 | 265.805 |
| 02:02 ET | 300 | 265.8 |
| 02:04 ET | 200 | 265.795 |
| 02:06 ET | 2053 | 265.44 |
| 02:08 ET | 100 | 265.35 |
| 02:13 ET | 300 | 265.225 |
| 02:15 ET | 100 | 265.16 |
| 02:18 ET | 402 | 264.96 |
| 02:20 ET | 950 | 265.22 |
| 02:22 ET | 400 | 265.13 |
| 02:24 ET | 1102 | 265.345 |
| 02:26 ET | 100 | 265.51 |
| 02:29 ET | 2868 | 265.14 |
| 02:31 ET | 636 | 264.87 |
| 02:33 ET | 1100 | 264.72 |
| 02:36 ET | 300 | 264.78 |
| 02:38 ET | 301 | 264.77 |
| 02:42 ET | 200 | 264.45 |
| 02:44 ET | 800 | 264.23 |
| 02:45 ET | 200 | 264.24 |
| 02:47 ET | 1600 | 264.5 |
| 02:51 ET | 1620 | 264.69 |
| 02:54 ET | 478 | 264.77 |
| 02:56 ET | 533 | 264.98 |
| 02:58 ET | 367 | 264.89 |
| 03:00 ET | 6100 | 265.005 |
| 03:02 ET | 797 | 264.88 |
| 03:03 ET | 1216 | 264.925 |
| 03:05 ET | 1600 | 264.795 |
| 03:07 ET | 500 | 265.455 |
| 03:09 ET | 1405 | 265.27 |
| 03:14 ET | 100 | 265.23 |
| 03:16 ET | 626 | 265.3 |
| 03:18 ET | 500 | 265.31 |
| 03:20 ET | 600 | 265.45 |
| 03:21 ET | 2407 | 265.56 |
| 03:23 ET | 100 | 265.52 |
| 03:25 ET | 2104 | 265.695 |
| 03:27 ET | 700 | 265.86 |
| 03:30 ET | 306 | 265.8625 |
| 03:32 ET | 2822 | 266.02 |
| 03:34 ET | 900 | 266 |
| 03:36 ET | 5034 | 265.965 |
| 03:38 ET | 2556 | 265.4 |
| 03:39 ET | 2999 | 265.005 |
| 03:41 ET | 1881 | 265.11 |
| 03:43 ET | 1241 | 265.265 |
| 03:45 ET | 1414 | 265.565 |
| 03:48 ET | 4827 | 265.41 |
| 03:50 ET | 3095 | 265.41 |
| 03:52 ET | 2351 | 265.43 |
| 03:54 ET | 3276 | 265.34 |
| 03:56 ET | 6826 | 265.9 |
| 03:57 ET | 4655 | 265.65 |
| 03:59 ET | 60668 | 266.05 |
May 3, 2024
DJ United Therapeutics Is Maintained at Neutral by Goldman Sachs, from 12:13PM ET on Friday May 03, 2024 by Dow Jones
12:13PM ET on Friday May 03, 2024 by Dow Jones
May 2, 2024
DJ United Therapeutics Is Maintained at Outperform by Oppenheimer, from 9:10AM ET on Thursday May 02, 2024 by Dow Jones
9:10AM ET on Thursday May 02, 2024 by Dow JonesDJ United Therapeutics Price Target Maintained With a $300.00/Share by HC Wainwright & Co., from 7:07AM ET on Thursday May 02, 2024 by Dow Jones
7:07AM ET on Thursday May 02, 2024 by Dow Jones
May 1, 2024
DJ United Therapeutics Up Over 8%, on Pace for Largest Percent Increase Since November 2022 -- Data Talk, from 2:56PM ET on Wednesday May 01, 2024 by Dow Jones
2:56PM ET on Wednesday May 01, 2024 by Dow JonesUnited Therapeutics Corporation Reports First Quarter 2024 Financial Results, from 6:30AM ET on Wednesday May 01, 2024 by Dow Jones
6:30AM ET on Wednesday May 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 11.6B | 12.6x | +8.22% |
Exact Sciences Corp | 10.9B | -47.7x | --- |
Medpace Holdings Inc | 12.0B | 40.7x | +35.10% |
Qiagen NV | 9.5B | 28.6x | +12.66% |
Biomarin Pharmaceutical Inc | 15.5B | 77.4x | --- |
Neurocrine Biosciences Inc | 14.0B | 38.4x | +62.04% |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.6B |
|---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.47 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 12.6x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | 10.5x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
